Clinician adherence to peri-procedural warfarin bridging guidelines for patients with atrial fibrillation enrolled in an anticoagulation management service.
BACKGROUND The 2023 AHA/ACC/HRS guidelines recommend against peri-procedural bridging of warfarin in patients with atrial fibrillation (AF) based solely on CHA₂DS₂-VASc score without additional thromboembolic (TE) risk factors. At our institution, decisions regarding bridging in moderate-to-high TE risk AF patients who...